[Therapeutic effect of heterologous antihuma lymphocyte serum (AHLS) in chronic lympahtic leukemia].
D000910:Antibodies, Heterophile; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001792:Blood Platelets; D006801:Humans; D007116:Immunization, Passive; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007958:Leukocyte Count; D008214:Lymphocytes; D013997:Time Factors
D000910:Antibodies, Heterophile; D000961:Antilymphocyte Serum
Surg Gynecol Obstet. 1967 Jan;124(1):1-24
6016025
Prog Allergy. 1962;6:30-154
14482809
Surg Gynecol Obstet. 1967 Feb;124(2):301-8
4163340
Neoplasma. 1963;10:621-39
14103649
Prog Allergy. 1967;10:84-150
5333529
Klin Wochenschr. 1968 Aug 15;46(16):856-64
5749995
Klin Wochenschr. 1968 Mar 1;46(5):249-58
5697853
Z Gesamte Exp Med. 1967;143(2):161-226
5584706
Prog Allergy. 1958;5:1-78
13578996
Therapeutische Wrikungen Von heterologem Antihumanlympnocytenserum (AHLS0 bei chronischer lymphaischer Leukämie.